Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

Research Advisory Committee on Gulf War Veterans' Illnesses


Quick Links

Veterans Crisis Line Badge
My healthevet badge
EBenefits Badge

Research Update - June 2009


The following journal articles were distributed for review in June 2009. You can access the article's abstract by copying the paper title and pasting it into the search bar of the PubMed website, linked here. 

Gulf War Specific Articles

1. Gulf War illness: Effects of repeated stress and pyridostigmine bromide treatment on blood-brain barrier permeability and cholinesterase activity in rat brain. (Amourette C, Lamproglou I, Barbier L, Fauquette W, Zoppe A, Viret R, Diserbo M. Behav Brain Res. 2009 May 9:1-8. [Epub ahead of print])

2. Neuropsychological issues in military deployments: Lessons observed in the DoD Gulf War illnesses research program. (Friedl KE, Grate SJ, Proctor SP. Mil Med. 2009 Apr;174(4):335-346.)

3. Pituitary response to metyrapone in Gulf War veterans: Relationship to deployment, PTSD and unexplained health symptoms. (Golier JA, Schmeidler J, Yehuda R. Psychoneuroendocrinology. 2009 May 13:1-8. [Epub ahead of print])

4. Health of US veterans of 1991 Gulf War: A follow-up survey in 10 years. (Kang HK, Li B, Mahan CM, Eisen SA, Engel CC. J Occup Environ Med. 2009 Apr;51(4):401-410.) 

5. Antibodies to squalene in US Navy Persian Gulf War veterans with chronic multisymptom illness. (Phillips CJ, Matyas GR, Hansen CJ, Alving CR, Smith TC, Ryan MAK. Vaccine. 2009:1-6. [Epub ahead of print])

Other Relevant Research

1. Two-generation reproductive toxicity study of implanted depleted uranium (DU) in rats. (Arfsten DP, Still KR, Wilfong ER, Johnson EW, McInturf SM, Eggers JS, Schaeffer DJ, Bekkedal MY-V. J Toxicol Environ Health A. 2009;72(6):410-427.)

2. From inflammation to sickness and depression: when the immune system subjugates the brain. (Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. Nat Rev Neurosci. 2009 Jan;9:46-57.)

3. Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance. (Davis JM, Murphy EA, Carmichael MD, Davis B. Am J Physiol Regul Integr Comp Physiol. 2009 Apr;296(4):R1071-R1077.)

4. N,N,-Diethyl-m-Tolumide (DEET) suppresses humoral immunological function in B6C3F1 mice. (Keil DE , McGuinn WD, Dudley AC, EuDaly JG, Gilkeson GS, Peden-Adams MM. Toxicol Sci. 2009 Mar;108(1):110-123.)

5. Long-term study of brain 1H-MRS study in multiple sclerosis: Effect of glatiramer acetate therapy on axonal metabolic function and feasibility of long-term 1H-MRS monitoring in multiple sclerosis. (Khan O, Shen Y, Bao F, Caon C, Tselis A, Latif Z, Zak I. J Neuroimaging. 2008;18(3):314-319.)

6. The synergistic toxicity of pesticide mixtures: Implications for risk assessment and the conservation of endangered salmon. (Laetz CA , Baldwin DH, Collier TK, Hebert V, Stark JD, Scholz NL. Environ Health Perspect. 2009 Mar;117:348-353.

7. Solid state speciation and potential bioavailability of depleted uranium particles from Kosovo and Kuwait. (Lind OC, Salbu B, Skipperud L, Janssens K, Jaroszewicz J, De Nolf W. J Environ Radioact. 2009 Apr;100(4):301-307.)

8. Overview of the Capstone depleted uranium study of aerosols from impact with armored vehicles: test setup and aerosol generation, characterization, and application in assessing dose and risk. (Parkhurst MA, Guilmette RA. Health Phys. 2009 Mar;96(3):207-220.)

9. Conclusions of the Capstone depleted uranium aerosol characterization and risk assessment study. (Parkhurst MA, Guilmette RA. Health Phys. 2009 Mar;96(3):393-409.)  

10. Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. (Riordan NH, Ichim TE, Min W-P, Wang H, Solano F, Lara F, Alfaro M, Rodriguez JP, Harman RJ, Patel AN, Murphy MP, Lee RR, Minev B. J Transl Med. 2009 Apr 24;7:29.)

11. Halofuginone inhibits TH17 cell differentiation by activating the amino acid starvation response. (Sundrud MS, Koralov SB, Feuerer M, Calado PD, Kozhaya AEH, Rhule-Smith A, Lefebvre RE, Unutmaz D, Mazitschek R, Waldner H, Whitman M, Keller T, Rao A. Science. 2009; 324:1334-1338.)